Meeting Coverage
SITC
Society for Immunotherapy of Cancer
Latest SITC Meeting Coverage
CTX130 yields sustained complete response in one patient with relapsed/refractory disease
November 15, 2022
Encouraging activity with antibiotic-free protocol but not with vancomycin preconditioning
November 14, 2022
Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo
November 13, 2020
Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance
November 11, 2020
Latest Oncology/Hematology Meeting Coverage
-
AHNS: American Head & Neck Society
July 2023
-
ASCO Future Focus: Immunotherapy: Future Focus from the American Society of Clinical Oncology
June 2023
-
ASCO Video Pearls: Immunotherapy: Video Pearls from the American Society of Clinical Oncology
June 2023
-
ASCO Video Pearls: Renal Cell Carcinoma: Video Pearls from the American Society of Clinical Oncology
June 2023